It will also conduct research through a mobile app that will track patient symptoms for aggregate analyses. RELATED: Migraine maven Lilly finds 'understanding gap' between patients, nonpatients in new survey Bar-Zohar emphasized that the study was not connected to the commercialization of Aimovig but rather had the goal of studying and understanding the economic, social and emotional impact of migraines. Novartis and Amgen launched a migraine awareness campaign last year called "Speak Your Migraine" in digital and social.